[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100562660":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":25,"centralContacts":30,"locations":37,"responsibleParty":60,"collaborators":62,"id":68,"slug":69,"hasResults":70,"nctId":71,"briefTitle":72,"officialTitle":73,"acronym":74,"eligibilityCriteria":75,"healthyVolunteers":70,"sex":76,"minAge":77,"maxAge":25,"enrollmentInfo":78,"targetDuration":25,"studyType":81,"phases":82,"briefSummary":84,"conditions":85,"keywords":89,"overallStatus":94,"whyStopped":25,"lastUpdateSubmitDate":95,"lastUpdatePostDateStruct":96,"startDateStruct":99,"completionDateStruct":101,"leadSponsor":103,"locationsCount":104},{"fullName":5,"class":6},"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"No intervention","PLACEBO_COMPARATOR","This group will not receive any of the educational and\u002For implementation Neurocardiology until the data collection is completed.",[13],"Other: No educational or implementation tool will be provided",{"label":15,"type":16,"description":17,"interventionNames":18},"Intervention arm","ACTIVE_COMPARATOR","Sites randomized in this arm will receive the educational and implementation Neurocardiology tool with the aim of improving adherence to best practice recommendations for secondary stroke prevention of cardioembolic strokes, as defined by the WSO Systematic Review and Synthesis of Global Stroke Guidelines or more recent high-quality evidence published after the last stroke guidelines.",[19],"Other: Educational and implementation Neurocardiology tool",[21,26],{"type":6,"name":22,"description":23,"armGroupLabels":24,"otherNames":25},"Educational and implementation Neurocardiology tool","Sites in this arm will be provided with an educational and implementation Neurocardiology tool aiming to improve adherence to best practice recommendations for secondary stroke prevention of cardioembolic strokes, as defined by the WSO Systematic Review and Synthesis of Global Stroke Guidelines or more recent high-quality evidence published after the last stroke guidelines1.",[15],null,{"type":6,"name":27,"description":28,"armGroupLabels":29,"otherNames":25},"No educational or implementation tool will be provided","Participants will be followed for up to 12 months. No educational or interventional tool will be provided to sites in this arm until the follow-up period has ended.",[9],[31],{"name":32,"role":33,"phone":34,"phoneExt":35,"email":36},"Diana Ayan, Pharm MSc","CONTACT","519-685-8500","35826","diana.ayan@lhsc.on.ca",[38],{"facility":39,"status":25,"city":40,"state":41,"zip":42,"country":43,"countryCode":44,"cosmosGeoPoint":45,"geoPoint":50,"contacts":51},"Heart &amp; Brain Lab, Western University","London","Ontario","N6A 5A5","Canada","CA",{"type":46,"coordinates":47},"Point",[48,49],-81.23304,42.98339,{"lat":49,"lon":48},[52,53,57],{"name":32,"role":33,"phone":34,"phoneExt":35,"email":36},{"name":54,"role":33,"phone":34,"phoneExt":55,"email":56},"Jennifer Moussa","33110","jennifer.moussa@lhsc.on.ca",{"name":58,"role":59,"phone":25,"phoneExt":25,"email":25},"Luciano Sposato, MD, MBA","PRINCIPAL_INVESTIGATOR",{"type":61,"investigatorFullName":25,"investigatorTitle":25,"investigatorAffiliation":25,"oldNameTitle":25,"oldOrganization":25},"SPONSOR",[63,66],{"name":64,"class":65},"W.L.Gore & Associates","INDUSTRY",{"name":67,"class":65},"Medtronic","100562660","wso-beat-stroke-initiative-100562660",false,"NCT06606054","WSO BEAT STROKE Initiative","WSO - The Brain and hEart globAl iniTiative (BEAT) Stroke","BEAT STROKE","Inclusion Criteria:\n\n* Patients with ischemic stroke or TIA of any etiology.\n\nExclusion Criteria:\n\n* N\u002FA","ALL","18 Years",{"count":79,"type":80},2400,"ESTIMATED","INTERVENTIONAL",[83],"NA","The WSO Brain and hEart globAl iniTiative - STROKE (BEAT-STROKE) is a cluster randomized controlled trial, testing whether an educational and implementation Neurocardiology tool can improve adherence to best practice recommendations for secondary stroke prevention of cardioembolic strokes, as defined by the WSO Systematic Review and Synthesis of Global Stroke Guidelines or more recent high-quality evidence published after the last stroke guidelines1",[86,87,88],"Stroke","PFO - Patent Foramen Ovale","Atrial Fibrillation (AF)",[90,91,92,93],"cardiac monitoring","stroke","atrial fibrillation","pfo closure","NOT_YET_RECRUITING","2025-03-27",{"date":97,"type":98},"2025-04-02","ACTUAL",{"date":100,"type":80},"2025-07",{"date":102,"type":80},"2026-12",{"name":5,"class":6},1]